IT took the Office of the Ombudsman half a decade to file plunder charges against the 46 personalities involved in the so-called Pharmally scandal embarking on an P11-billion worth of contracts during the Covid-19 pandemic.
The contracts deemed spurious involved procurement deals for the purchase of medical equipment, supplies and personal protective equipment (PPE).
The worst part — 23 of the 46 personalities facing charges have evaporated like gas.
Still the Ombudsman proceeded with the filing of the complaint of the officers and people behind Pharmaly Pharmaceutical Corp., an undercapitalized newbie company that got the entire procurement funds for PPEs and other pandemic supplies through its connection with the top officials of former President Rodrigo Duterte.
The questionably overpriced and inferior items supplied by Pharmally coming directly from China were PPEs, coronavirus testing kits, among others, during the Covid-19 pandemic, Ombudsman Jesus Crispin Remulla said on Friday.
“The Pharmally case… there are 46 respondents [in our complaint], that’s why it took a while. And many of them have become invisible. It’s as if they’re trying to evade the jurisdiction of this body,” the Ombudsman told reporters.
Among the respondents are Lloyd Christopher Lao, former head of the Procurement Service-Department of Budget and Management (PS-DBM), and businessman Michael Yang, a former economic adviser of former president Rodrigo Duterte.
In August 2025, Lao pleaded not guilty before the Sandiganbayan Fifth Division regarding the alleged anomalous purchase of P4.4-billion worth of medical supplies from Pharmally during the height of the Covid-19 pandemic.
The missing persons included in the plunder charge are: Huang Tzu Yen, Pharmally chairman; Twinkie Dargani, Pharmally president; Mohit Dargani, Pharmally corporate secretary and treasurer; Linconn Uy Ong, Pharmally director; Krizle Grace Mago, Pharmally head of regulatory affairs; Lin Wei Xiong, Pharmally financial manager; associate of Michael Yang.
Also included in the list are Rose Nono Lin, Pharmally biological officer; Yang Hong Ming aka Michael Yang, former economic adviser to former president Rodrigo Duterte; tagged as Pharmally financier; Yang Hong Jiang (Tany Yang), Brother of Michael Yang; Pai Li Holdings director; Jayson Uson, Pai Li Holdings / Pai Hong Realty director; Yuqin Zheng, Pai Li Holdings director.
Likewise dragged into the case are Justine Garado, Pharmally director; Mervin Ian Tanquintic, former PS-DBM personnel; Alvin Fernandez; Gilbert Recluta; Orly Delos Reyes; Nelson Taguik; Gerald Cruz; Adriano I. Po, Jr.; Ma. Joycelynn Lee Rodriguez; Mark Augustine Lee Rodriguez; Michael Angelo Santos Rodriguez; and Mikhail Francesco Lee Rodriguez.
Pharmally Pharmaceutical Corporation was established on September 4, 2019 with a paid up capital of only P625,000, but it cornered P11 billion worth of medical supply contracts with the Philippine government through the DBM-PS and the Department of Health. It had its corporate headquarters at Fort Victoria Tower B in Fort Bonifacio, Taguig City.
Its key officers/owners as of its establishment were: Huang Tzu Yen (Chairman, 40% stake); Mohit Dargani (Corporate Secretary & Treasurer, 30%); Linconn Ong (Director, 16%); Twinkle Dargani (President, 10%) and Justine Garado (Director, 4%).
Between 2020 and 2021, Pharmally bagged roughly ₱10.85 billion in government medical supply contracts (including face masks, face shields, personal protective equipment, and RT-PCR test kits) from agencies like the Procurement Service-Department of Budget and Management (PS-DBM), led then by Lloyd Christopher Lao.
Despite having a tiny capital of ₱625,000 and zero track record or sales in 2019, the company suddenly landed massive awards under the Bayanihan law provisions.
The company was flagged for issues like: gross overpricing of medical items (such as face masks and test kits) compared to market rates; involvement of middlemen and sourcing from local suppliers (like Tigerphil Marketing) before reselling to the state at inflated prices; financing links tied to Michael Yang, Duterte’s former economic adviser, who allegedly helped backstop the cash-strapped firm and executive luxuries like purchases of several luxury vehicles by company officials shortly after receiving government payouts.
The Senate Blue Ribbon Committee investigated the transactions in 2021 and recommended filing plunder and graft charges against involved government officials and Pharmally executives.
The Office of the Ombudsman and related anti-graft bodies moved forward with legal action. Former PS-DBM head Lloyd Christopher Lao and various Pharmally figures faced charges, including an ₱11-billion plunder complaint filed involving dozens of respondents.
